Correlation Between Morgan Stanley and Relief Therapeutics

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Relief Therapeutics Holding, you can compare the effects of market volatilities on Morgan Stanley and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Relief Therapeutics.

Diversification Opportunities for Morgan Stanley and Relief Therapeutics

0.14

Correlation Coefficient

Morgan Stanley  Relief Therapeutics

Average diversification

The 3 months correlation between Morgan and Relief is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Relief Therapeutics go up and down completely randomly.

Pair Corralation between Morgan Stanley and Relief Therapeutics

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.24 times more return on investment than Relief Therapeutics. However, Morgan Stanley Direct is 4.2 times less risky than Relief Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about 0.01 per unit of risk. If you would invest  1,907  in Morgan Stanley Direct on September 21, 2024 and sell it today you would earn a total of  157.00  from holding Morgan Stanley Direct or generate 8.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	46.46%
Values	Daily Returns

Morgan Stanley Direct  vs.  Relief Therapeutics Holding

Morgan Stanley Direct

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental indicators, Morgan Stanley is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Relief Therapeutics

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Relief Therapeutics Holding are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Relief Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and Relief Therapeutics

The main advantage of trading using opposite Morgan Stanley and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.

The idea behind Morgan Stanley Direct and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.